Predictive Value of PS Application in Premature Infants With RDS

Not yet recruiting

• Conditions: Respiratory Distress Syndrome
• Interventions: Diagnostic Test: Lung ultrasound

• Registration Number: NCT05772247
• Lead Sponsor: The First Hospital of Jilin University

Brief Summary

A multicenter prospective study was conducted to compare the predictive value of 6-zone, 10-zone, and 12-zone LUS scores for PS application in early and late preterm infants.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-02
• Study First Submitted: 2023-02-12
• Study First Submitted QC: 2023-03-15
• Last Update Submitted: 2023-03-15
• Study First Posted: 2023-03-16
• Last Update Posted: 2023-03-16
• Study Start: 2023-04-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 1392

Inclusion Criteria

1. Hospital admission within 2 hours after birth;
2. The diagnosis was RDS;
3. Parents agree to attend

Exclusion Criteria

1. chromosomal abnormalities or complex congenital malformations;
2. congenital pulmonary disease;
3. severe sepsis, disseminated intravascular coagulation, septic shock and other critical conditions;
4. LUS and blood gas analysis have been examined before the application of alveolar surfactant.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
non-PS application	Lung ultrasound	-
PS application	Lung ultrasound	-

Primary Outcome Measures

Name	Time	Method
Whether the patient uses ps (pulmonary surfactant)	2023.2-2023.12	The standards used by PS are based on the European consensus